Treatment of cachexia with interleukin 2
AssigneeThe Brigham and Women's Hospital, Inc.
InventorDavid B. Gough
Life of this patent
Estimating the term…
Abstract
A method of treating cachexia associated with cancer, infectious diseases, or catabolic disorders which comprises administration of an effective amount of interleukin 2 is disclosed.
Claims20
A method of treating cachexia in an animal comprising administering to said animal a therapeutically effective amount of interleukin 2 or a functional analogue thereof which retains the characteristics of interleukin 2.
A method of treating symptoms substantially associated with excessive monocyte stimulation caused by endotoxin in an animal, comprising administering to said animal a therapeutically effective amount of interleukin 2 or a functional analogue thereof which retains the characteristics of interleukin 2.
Dependencies are inferred from the claim text.